Trials / Completed
CompletedNCT01112579
Determining the Feasibility of Spinal Cord Neuromodulation for the Treatment of Chronic Heart Failure
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 81 (actual)
- Sponsor
- Medtronic Cardiac Rhythm and Heart Failure · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine the feasibility of spinal cord stimulation (SCS) as a chronic therapy for systolic heart failure.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Medtronic PrimeADVANCED Neurostimulator | Heart failure therapy |
| DEVICE | Medtronic PrimeADVANCED Neurostimulator | Medical management |
Timeline
- Start date
- 2010-04-01
- Primary completion
- 2014-01-01
- Completion
- 2015-04-01
- First posted
- 2010-04-28
- Last updated
- 2015-10-29
- Results posted
- 2015-10-29
Locations
19 sites across 8 countries: United States, Canada, Czechia, Germany, Italy, Netherlands, South Africa, Sweden
Source: ClinicalTrials.gov record NCT01112579. Inclusion in this directory is not an endorsement.